Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Access to diabetes care for children and young people: Pharma companies’ current actions and…
A recently released report from Access to Medicine Foundation highlights that children and young people living in low-and…
Data cleaning and harmonisation: A catalyst for innovation
Messy data remains a persistent challenge in modern drug discovery. The complementary processes of data cleaning and data…
Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData
GlobalData analysts highlight uncertainty around new FDA directives as pharma giants ramp up US-based manufacturing investments…
Parexel completes CRO registration with CDSCO under new G.S.R 581(E) regulation
Parexel aligns with CDSCO regulatory framework, ensuring continued clinical trial operations in India
OneSource Specialty Pharma’s Bangalore facility maintains US FDA compliance with VAI classification
US FDA concludes inspection of OneSource’s flagship site with Voluntary Action Indicated status, confirming regulatory adherence…
Cadila Pharmaceuticals launches Biscado (Bisoprolol) for cardiovascular disease management in India
Biscado enters India’s beta-blocker therapy space, addressing the growing burden of heart disease with clinically supported…
CII Telangana to host “Pillars of Protection”conference on pharma and chemical safety
Hyderabad to host industry-wide dialogue on safety, compliance, and risk management in pharma and chemical manufacturing on 25th…
Pharma sector sees $6.96 billion in global deal activity in May 2025, led by GSK, Shionogi, and Eli…
M&A and venture capital deals in the global healthcare sector declined from the 12-month average, with three transactions…
Lupin receives tentative US FDA approval for Oxcarbazepine ER tablets
Oxcarbazepine extended-release tablets to be manufactured at Lupin’s Nagpur facility for US market
Supriya Lifescience’s Saloni Wagh and Shivani Wagh named in 2025 Candere Hurun India Women Leaders…
Leadership of Saloni Wagh and Shivani Wagh recognised as Supriya Lifescience posts highest-ever revenue in FY25